Li et al. showed that inhibiting METTL3 could block the proliferation and self-renewal of glioma stem cells (GSC), suggesting upregulated METTL3 leads to highly aggressive GBM (Li et al., 2019). The gene discussed is METTL3; the disease is central nervous system cancer.